ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

St. John's wort (flowering herb)

Also known as: Hypericum perforatum, St. John's wort, perforate St John's-wort, goatweed

Overview

St. John's wort (SJW), scientifically known as *Hypericum perforatum*, is a flowering herb primarily used as a herbal treatment for mild to moderate depression. Native to Europe but now widespread globally, SJW contains active constituents such as hypericin, hyperforin, and various flavonoids. Extracts are typically standardized by hypericin content. Research on SJW is extensive, with numerous randomized controlled trials (RCTs) and meta-analyses evaluating its efficacy and safety in treating depression. The evidence is generally strong for mild to moderate depression, demonstrating effectiveness comparable to standard antidepressants, but less robust for severe depression due to limited studies. SJW is available in various forms, including capsules, tablets, and liquid extracts, derived from the aerial parts of the plant.

Benefits

St. John's wort has demonstrated efficacy in treating mild to moderate major depressive disorder (MDD), showing superiority to placebo. Meta-analyses indicate a significantly higher likelihood of response compared to placebo. It has also shown comparable efficacy to standard antidepressants (e.g., SSRIs) in improving symptoms, with a more favorable safety profile. Evidence supports its use primarily in adults with mild to moderate depression, while data on severe depression are insufficient. Benefits typically emerge within 4 to 6 weeks of treatment, consistent with conventional antidepressants. Studies report statistically significant improvements over placebo (p < 0.05) with moderate effect sizes, supporting its clinical relevance.

How it works

St. John's wort's antidepressant effects are attributed to multiple mechanisms. It inhibits the reuptake of neurotransmitters serotonin, dopamine, and norepinephrine, thereby increasing their availability in the synaptic cleft. Hyperforin is considered a key active compound responsible for this neurotransmitter reuptake inhibition. Additionally, SJW modulates inflammatory pathways and exerts antioxidant effects, contributing to its overall therapeutic action. The herb also influences various molecular targets, including GABA and glutamate receptors. Oral bioavailability varies by extract formulation, with standardized extracts ensuring consistent delivery of active compounds.

Side effects

St. John's wort is generally safe and well-tolerated, but it can cause side effects. Common side effects include gastrointestinal symptoms (nausea, diarrhea), dizziness, dry mouth, and fatigue. Uncommon side effects include allergic reactions, photosensitivity (sensitivity to sunlight), and headache. Rare but serious side effects include severe allergic reactions and serotonin syndrome, particularly when combined with other serotonergic drugs. SJW induces cytochrome P450 enzymes (especially CYP3A4) and P-glycoprotein, leading to reduced plasma concentrations of many drugs, including oral contraceptives, anticoagulants, immunosuppressants, and antiretrovirals. It is contraindicated for use with other antidepressants or serotonergic drugs without medical supervision, as well as during pregnancy and breastfeeding due to insufficient safety data. Caution is advised in elderly patients and those on multiple medications due to the risk of drug interactions.

Dosage

The typical minimum effective dose of St. John's wort is standardized extracts containing 0.3% hypericin at 300 mg three times daily (900 mg/day total), as used in many RCTs. An optimal dosage often ranges from 900 to 1200 mg/day of standardized extract for treating depression. Doses above 1200 mg/day have been used but may increase the risk of side effects. It is recommended to take oral administrations with meals to improve absorption and reduce gastrointestinal discomfort. Use standardized extracts to ensure consistent hypericin/hyperforin content. Bioavailability may be affected by formulation; lipophilic extracts may have better absorption. Monitoring for drug interactions is essential.

FAQs

Is SJW safe to use with other antidepressants?

No, combining SJW with other serotonergic drugs can increase the risk of serotonin syndrome. Medical supervision is necessary to avoid adverse effects.

How long does it take to see effects?

Clinical improvement is typically observed within 4 to 6 weeks of consistent use, similar to the timeline for conventional antidepressants.

Can SJW cause photosensitivity?

Yes, rare cases of photosensitivity have been reported. It is advised to use sun protection measures while taking St. John's wort.

Is SJW effective for severe depression?

Evidence is insufficient and inconsistent. It is not recommended as a monotherapy for severe depression; consult a healthcare provider.

Does SJW interact with birth control?

Yes, it can reduce the effectiveness of oral contraceptives due to enzyme induction. Alternative contraception methods should be considered.

Research Sources

  • https://advances.umw.edu.pl/en/article/2023/32/2/151/ – This article likely discusses the efficacy and safety of St. John's Wort, potentially comparing it to other treatments for depression. Further review of the full article would be needed to extract specific findings and methodologies.
  • https://pubmed.ncbi.nlm.nih.gov/27589952/ – This study is a systematic review and meta-analysis indicating that St. John's wort is superior to placebo and comparable to antidepressants for mild to moderate depression. It also notes fewer adverse events compared to standard antidepressants, though it acknowledges limited data on severe depression and poor adverse event reporting.
  • https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/485215 – This study likely examines the effectiveness of St. John's Wort in treating depression, potentially comparing it to other treatments or a placebo. The full article would need to be reviewed to determine the specific findings and methodologies used.
  • https://www.cureus.com/articles/94821-advantages-and-disadvantages-of-using-st-johns-wort-as-a-treatment-for-depression – This article discusses the advantages and disadvantages of using St. John's Wort for depression. It likely covers aspects such as efficacy, side effects, drug interactions, and patient suitability, providing a balanced perspective on its use as a treatment option.
  • https://mentalhealth.bmj.com/content/12/3/78 – This article likely focuses on the mental health aspects of using St. John's Wort, potentially exploring its impact on various mental health conditions beyond depression. Reviewing the full article would provide insights into its specific applications and limitations in mental health treatment.